Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells | Journal of Experimental & Clinical Cancer Research | Full Text

Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells | Journal of Experimental & Clinical Cancer Research | Full Text

Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells

CAR T cell-based therapies have shown promising results in hematological malignancies. Results of CAR T cell projects in solid tumors have been less impressive, and factors including lack of targetable antigen...

Authors:Elham Masoumi, Leila Jafarzadeh, Hamid Reza Mirzaei, Khadijeh Alishah, Keyvan Fallah-Mehrjardi, Hosein Rostamian, Mohammad Khakpoor-Koosheh, Reza Meshkani, Farshid Noorbakhsh and Jamshid Hadjati

Citation:Journal of Experimental & Clinical Cancer Research 2020 39:49

Content type:Research

Published on: 10 March 2020

• ViewFull Text
 
• ViewPDF